USPTO serial 99323826
A
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 7, 2026
- Examiner
- LAVACHE, LINDA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with A?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Abbott Park, IL, US
Abbott Park, IL, US
Abbott Park, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott Park, IL 60064United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing temporary use of on-line non-downloadable software for sharing, reporting, maintaining, managing, monitoring and analyzing of medical information in the field of diabetes management; Providing a website featuring on-line non-downloadable software that enables users to share, report, maintain, manage, monitor and analyze medical information in the field of diabetes management; Software as a service (SAAS) services featuring software for sharing, reporting, maintaining, managing, monitoring and analyzing of medical information in the field of diabetes management; providing temporary use of non-downloadable web-based software for remote patient medical monitoring, in the nature of collecting, transmitting, analyzing, and managing health data, testing results, and medical device functionality information; software as a services (SaaS) services featuring software for remote patient monitoring in the nature of collecting, transmitting, analyzing, and managing health data, testing results, and medical device functionality information; providing a web-based service featuring technology that enables patients and medical providers to access healthcare information; providing temporary use of non-downloadable cloud-based software platforms for managing and documenting medical therapies and disease states; providing online, non-downloadable software for enabling secure electronic communication between medical providers and patients; providing online, non-downloadable software for electronically managing and processing patient health data; providing technical support services, namely, troubleshooting, in the nature of diagnosing problems with medical devices and electrophysiology equipment and providing remote updating of software therefor; providing technical support via telephone for patients with implanted medical devices, namely, providing technical advice relating to the configuration of implanted medical device monitoring equipment and troubleshooting in the nature of diagnosing problems with devices which monitor performance of implanted medical devices; providing online non-downloadable software for medical diagnosis concerning cardiovascular conditions and diseases; providing online non-downloadable software for medical diagnosis concerning the field of cardiology, including measurement and assessment of physiological variables and intravascular imaging; clinical medical research and providing information about results of medical and scientific research in the field of transcatheter medical devices; consulting services regarding medical diagnostic software; consulting services regarding medical software; consulting services regarding software in the field of health; installation, maintenance and repair of software related to medical diagnostic instruments; providing technical support, namely, troubleshooting of problems regarding laboratory software in the field of medical diagnostics; consulting services in the field of scientific and medical laboratory testing; consulting services regarding the quality control of laboratory instruments for the purpose of gathering operational data and testing data; consulting services regarding the quality control of medical diagnostic instruments for the purpose of gathering operational data and testing data; installation, maintenance and repair of software related to medical diagnostic instruments; remote electronic operational monitoring of diagnostic laboratory systems, laboratory automation systems, and medical diagnostic instruments to ensure proper functioning; providing platform as a service (PAAS) services featuring a web-based software platform for laboratory and medical diagnostic information management; software as a service (SAAS) services featuring software for laboratory and diagnostic equipment information management, monitoring and analysis in the field of medical diagnostics; software as a service (SAAS) services featuring software for laboratory and diagnostic equipment information management, monitoring and analysis services in the field of health; platform as a service (PAAS) in the field of health, featuring software platforms for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; quality management evaluations of the medical diagnostic facilities of others to assess steps required to attain optimal efficiency, namely, conducting medical diagnostic testing facility evaluations to assess quality, environmental sustainability, waste, efficiency, operational downtime, flexibility and agility; conducting product research, monitoring and analysis regarding medical diagnostic instruments, tests and assays, namely, evaluations of the quality and performance of medical diagnostic instruments, tests and assays; product quality evaluation, namely, compiling, analyzing and reporting information regarding the performance of medical diagnostic instruments, tests and assays; quality control for others in the fields of medical laboratory equipment operations, medical laboratory inventory management, and medical laboratory quality management; product quality evaluation in the nature of tracking, analyzing and reporting of performance data for medical diagnostic equipment using computers and sensors; software as a service (SAAS) services featuring software for managing, integrating and facilitating access to medical and patient care data, for point of care data management, and for providing interfaces between medical diagnostic devices and laboratory information systems; software as a service (SAAS) services featuring software for scientific purposes for toxicology reporting in the fields of forensics and drug testing; software as a service (SAAS) services featuring software for scientific purposes for facilitating testing and analysis in the fields of forensics and drug testing; hosting a website featuring online databases for the provision of information in the fields of toxicology, forensics, and drug testing; updating of software; laboratory toxicology services, namely, toxicology testing for scientific, forensic, and medical research purposes; laboratory drug testing services for forensic purposes; design and development of computer software for use with medical and nonmedical technology; providing technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment and related computer hardware and software, monitoring for the purpose of determining the need for repair for medical diagnostic instruments and related computer software and hardware; providing operational monitoring services for medical diagnostic instruments to ensure proper functioning; remote monitoring of medical diagnostic systems to ensure proper functioning; providing remote electronic monitoring of medical diagnostic instruments to ensure proper functioning; providing a web-based non-downloadable software platform for data management, monitoring and analysis in the field of medical diagnostics; computer services, namely, providing a web-based non-downloadable software platform for data management, tracking, reporting, sharing, monitoring and analysis for medical diagnostic instruments; computer services, namely, providing a web-based non-downloadable software platform for data management, tracking, reporting, sharing, monitoring and analysis for medical diagnostic systems; providing information in the field of performance testing of medical diagnostic instruments; providing an on-line network environment that features technology that enables users to share data in the field of medical diagnostics; providing temporary use of non-downloadable software and software applications for monitoring medical diagnostic instruments and managing data from medical diagnostic instruments; providing a website featuring technology that enables users to manage drug and alcohol testing data, and to order, schedule and pay for drug and alcohol screening testing services; providing a website featuring technology that enables users to obtain test results of drug and alcohol screening tests; software as a service (SaaS) services featuring software for hiring program management, for managing automated random drug testing procedures and information, and for managing information regarding electronic physical examinations; providing temporary use of a web-based software application for transmitting, storing and reporting medical exam results, duplicating data and digital information, creating and managing digital images of standardized employment medical forms, online scheduling of medical appointments, downloading and completing medical and health forms and online tracking of medical exams results; platform as a service (PAAS) services featuring a web-based software platform in the field of health, for monitoring medical laboratory operations; platform as a service (PAAS) services featuring a web-based software platform in the field of medical diagnostics, for analyzing bodily fluid and tissue samples | ACTIVE | Sep 17, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 7, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 19, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 11, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 11, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 6, 2025 | NWAP | NEW APPLICATION ENTERED | — |